Myrcludex B

The motto of this year's World Hepatitis Day, proclaimed annually on 28 July by the World Health Organisation (WHO), is “It's time to act". Hundreds of millions of people worldwide are affected by

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as

Joint press release from Heidelberg University and the German Center for Infection Research (DZIF)

What started off as basic research 25 years ago has now led to a successfully approved drug: The

Researchers have for the first time succeeded in conquering a chronic infection with the hepatitis B virus in a mouse model. The team showed in its publication, that T-cell therapy can provide a